Hepatitis C Virus in the Modern Direct-Acting Antiviral Era: Where Have All the Special Populations Gone?
作者信息
Ramers Christian B, Trooskin Stacey B
机构信息
Family Health Centers of San Diego San Diego CA.
Division of Infectious Diseases, Department of Medicine UC San Diego School of Medicine La Jolla CA.
出版信息
Clin Liver Dis (Hoboken). 2018 Dec 14;12(5):143-149. doi: 10.1002/cld.786. eCollection 2018 Nov.
Abstract
摘要
相似文献
1
Hepatitis C Virus in the Modern Direct-Acting Antiviral Era: Where Have All the Special Populations Gone?现代直接作用抗病毒药物时代的丙型肝炎病毒：所有特殊人群都去哪儿了？
Clin Liver Dis (Hoboken). 2018 Dec 14;12(5):143-149. doi: 10.1002/cld.786. eCollection 2018 Nov.
2
Initial uptake, time to treatment, and real-world effectiveness of all-oral direct-acting antivirals for hepatitis C virus infection in the United States: A retrospective cohort analysis.美国丙型肝炎病毒感染全口服直接抗病毒药物的初始吸收率、治疗时间和真实世界疗效：一项回顾性队列分析。
PLoS One. 2019 Aug 22;14(8):e0218759. doi: 10.1371/journal.pone.0218759. eCollection 2019.
3
Changing Urban-Rural Disparities in the Utilization of Direct-Acting Antiviral Agents for Hepatitis C in U.S. Medicare Patients, 2014-2017.2014 - 2017年美国医疗保险患者中丙型肝炎直接抗病毒药物使用方面城乡差距的变化
Am J Prev Med. 2021 Feb;60(2):285-293. doi: 10.1016/j.amepre.2020.08.031. Epub 2020 Nov 19.
4
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.在澳大利亚新南威尔士州直接作用抗病毒治疗时代，丙型肝炎病毒相关肝病负担下降。
J Hepatol. 2019 Aug;71(2):281-288. doi: 10.1016/j.jhep.2019.04.014. Epub 2019 May 10.
5
Era of direct acting anti-viral agents for the treatment of hepatitis C.用于治疗丙型肝炎的直接作用抗病毒药物时代。
World J Hepatol. 2018 Oct 27;10(10):670-684. doi: 10.4254/wjh.v10.i10.670.
6
Use of Ribavirin for Hepatitis C Treatment in the Modern Direct-acting Antiviral Era.现代直接抗病毒药物时代利巴韦林在丙型肝炎治疗中的应用
J Clin Transl Hepatol. 2018 Dec 28;6(4):431-437. doi: 10.14218/JCTH.2018.00007. Epub 2018 Sep 27.
7
Sustained virologic response by direct-acting antivirals suppresses skeletal muscle loss in hepatitis C virus infection.直接作用抗病毒药物的持续病毒学应答可抑制丙型肝炎病毒感染所致的骨骼肌丢失。
J Gastroenterol Hepatol. 2020 Sep;35(9):1602-1609. doi: 10.1111/jgh.14991. Epub 2020 Feb 16.
8
[Diagnosis and treatment strategies of hepatitis C-related hepatocellular carcinoma in the era of direct-acting antiviral drugs].[直接作用抗病毒药物时代丙型肝炎相关肝细胞癌的诊断与治疗策略]
Zhonghua Gan Zang Bing Za Zhi. 2020 Oct 20;28(10):827-830. doi: 10.3760/cma.j.cn501113-20200914-00516.
9
Understanding and addressing hepatitis C reinfection in the oral direct-acting antiviral era.在口服直接抗病毒药物时代对丙型肝炎再感染的理解与应对
J Viral Hepat. 2018 Mar;25(3):220-227. doi: 10.1111/jvh.12859.
10
[Research progress of direct-acting antiviral drugs in the treatment of chronic hepatitis C-related cirrhosis].直接作用抗病毒药物治疗慢性丙型肝炎相关肝硬化的研究进展
Zhonghua Gan Zang Bing Za Zhi. 2024 Jan 20;32(1):87-90. doi: 10.3760/cma.j.cn501113-20231126-00237.
本文引用的文献
1
Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.《2019年丙型肝炎指南更新：美国肝病研究协会-美国传染病学会关于丙型肝炎病毒感染检测、管理及治疗的建议》
Hepatology. 2020 Feb;71(2):686-721. doi: 10.1002/hep.31060.
2
Universal Screening of Pregnant Women for Hepatitis C: The Time Is Now.对孕妇进行丙型肝炎普遍筛查：现在是时候了。
Clin Infect Dis. 2018 Oct 30;67(10):1493-1497. doi: 10.1093/cid/ciy586.
3
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.格卡瑞韦/哌仑他韦治疗丙型肝炎病毒与人类免疫缺陷病毒 1 型合并感染患者的疗效和安全性：EXPEDITION-2 研究。
Clin Infect Dis. 2018 Sep 14;67(7):1010-1017. doi: 10.1093/cid/ciy220.
4
Notes from the Field: Underreporting of Maternal Hepatitis C Virus Infection Status and the Need for Infant Testing - Oregon, 2015.实地记录：2015年俄勒冈州孕产妇丙型肝炎病毒感染状况报告不足及婴儿检测需求
MMWR Morb Mortal Wkly Rep. 2018 Feb 16;67(6):201-202. doi: 10.15585/mmwr.mm6706a6.
5
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.索磷布韦和维帕他韦治疗近期有注射吸毒史的丙型肝炎病毒感染（SIMPLIFY）：一项开放标签、单臂、4 期、多中心试验。
Lancet Gastroenterol Hepatol. 2018 Mar;3(3):153-161. doi: 10.1016/S2468-1253(17)30404-1. Epub 2018 Jan 6.
6
Increasing Prevalence of Hepatitis C among Hospitalized Children Is Associated with an Increase in Substance Abuse.住院儿童丙型肝炎患病率上升与药物滥用增加有关。
J Pediatr. 2018 Jan;192:159-164. doi: 10.1016/j.jpeds.2017.09.016. Epub 2017 Nov 6.
7
Hepatitis C in pregnancy: screening, treatment, and management.妊娠期丙型肝炎：筛查、治疗与管理
Am J Obstet Gynecol. 2017 Nov;217(5):B2-B12. doi: 10.1016/j.ajog.2017.07.039. Epub 2017 Aug 4.
8
Sofosbuvir and ribavirin in adolescents 12-17 years old with hepatitis C virus genotype 2 or 3 infection.索磷布韦和利巴韦林治疗丙型肝炎病毒基因型 2 或 3 感染的 12-17 岁青少年。
Hepatology. 2017 Oct;66(4):1102-1110. doi: 10.1002/hep.29278. Epub 2017 Aug 26.
9
Hepatitis C Virus Infection Among Women Giving Birth - Tennessee and United States, 2009-2014.2009 - 2014年田纳西州及美国分娩女性中的丙型肝炎病毒感染情况
MMWR Morb Mortal Wkly Rep. 2017 May 12;66(18):470-473. doi: 10.15585/mmwr.mm6618a3.
10
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.索磷布韦和维帕他韦治疗人类免疫缺陷病毒 1 型合并丙型肝炎病毒感染患者：一项开放标签、3 期研究。
Clin Infect Dis. 2017 Jul 1;65(1):6-12. doi: 10.1093/cid/cix260.
Zotero 插件